We evaluated DEFA5 treatment as a secretagogue, on immortalized colonic epithelial cells and colonoids to determine which subtypes of signatures are secreted that may be responsible for IBD inflammation and differentiation. The gene discussed is DEFA5; the disease is inflammatory bowel disease.